Saturday, July 03, 2021

breaking news: covaxin phase 3 trial results out: not bad

https://www.livemint.com/science/health/bharat-biotech-s-us-partner-says-covaxin-is-65-2-effective-against-delta-variant-11625270462245.html

it seems the results are published on medarxiv. of course we'll wait till they appear in the much-credentialed lancet.

No comments: